Viatris
VTRS · NASDAQ
$18.65+$0.39 (+2.14%)TodayMarket closed ·
Prev close $18.26
About VTRS
- Employees
- 30,000
- Headquarters
- Canonsburg, Pennsylvania
- Listed
- Feb 1, 1973
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Website
- viatris.com
Leadership
| Name | Title | Since |
|---|---|---|
| Melina Higgins | — | — |
| Scott Smith | — | 2022 |
| Mark Parrish | — | — |
| Theodora Mistras | — | — |
| Paul Campbell | — | — |
| Andrew Enrietti | — | — |
| Corinne Le Goff | — | — |
| Matthew Maletta | — | — |
| Brian Roman | — | — |
| Hemanth Varghese | — | — |
| Rajiv Malik | — | 2020 |
| Rogerio Coelho | — | — |
| Wyllie Cornwell | — | — |
| Frank D'Amelio | — | — |
| JoEllen Dillon | — | — |
| Elisha Finney | — | — |
| Leo Groothuis | — | — |
| James Kilts | — | — |
| Harry Korman | — | — |
| Richard Mark | — | — |
| Michael Severino | — | — |
| David Simmons | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2025: $14.25B total revenue
By product
- Brands$9.18B64.4%
- Generics$5.07B35.6%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Bausch Health BHC | Supplier and customer | 0.75 |
| Vivimed Labs | Supplier | 0.72 |
| Lupin | Supplier and customer | 0.70 |
| SMS Pharmaceuticals | Supplier | 0.69 |
| Sonoma Pharmaceuticals SNOA | Supplier | 0.64 |
| NATCO Pharma | Supplier | 0.64 |
| UniFirst UNF | Supplier | 0.63 |
| Evofem Biosciences EVFM | Supplier and customer | 0.62 |
| Titan Pharmaceuticals TTNP | Supplier and customer | 0.61 |
| Mabion MAB.WA | Supplier | 0.61 |
Similar companies
Companies in the same industry as Viatris
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.